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Abstract In past few decades, scientists have made tremen-
dous advancement in the field of drug delivery systems
(DDS), through transdermal pathway, as the skin represents a
ready and large surface area for delivering drugs. Efforts are in
progress to design efficient transdermal DDS that support
sustained drug release at the targeted area for longer duration
in the recommended therapeutic window without producing
side-effects. Poly(lactic-co-glycolic acid) (PLGA) is one of
the most promising Food and Drug Administration approved
synthetic polymers in designing versatile drug delivery car-
riers for different drug administration routes, including
transdermal drugdelivery. The present reviewprovides a brief
introduction over the transdermal drug delivery and PLGA as
a material in context to its role in designing drug delivery
vehicles. Attempts are made to compile literatures over
PLGA-based drug delivery vehicles, including microneedles,
nanoparticles, and nanofibers and their role in transdermal
drug delivery of different therapeutic agents. Different
nanostructure evaluation techniques with their working prin-
ciples are briefly explained.
Keywords Drug delivery system  Transdermal drug
delivery  PLGA  Microneedles  Electrospinning
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Introduction
Recent advancements in the field of nanotechnology have
enabled the development of new approaches for the treat-
ment of several diseases, to minimize side-effects and to
design more efficient and controlled drug delivery systems.
Nanotechnology refers to the characterization, fabrication,
and applications of active substances in nanometer scale
dimension for various end uses (Sridhar et al. 2015). The
desired drug dosage and the therapeutic window is one of
the primary criteria to be considered while designing drug
delivery systems (DDS). By employing nanomaterials as a
base for drug delivery nanocarriers, it is now possible to
encapsulate a variety of important therapeutic agents, such
as nucleic acids, peptide protein-based drugs, and small
molecules either hydrophobic or hydrophilic, which helps
enhancing the therapeutic bioavailability at the targeted
area while minimizing the toxicity in healthy cells. The
stability and solubility of drugs can also be monitored by
encapsulating different molecules and chemicals into the
nanocarrier (Langer 1998). A preferable biological nano-
material should possess certain characteristics, such as:
chemical compatibility with physiological solutions; non-
toxic, biodegradable, and biocompatible; easy to design
and modify; preferably the usage of natural/biological
materials (Korrapati et al. 2015).
The stratum corneum layer of the epidermis is respon-
sible for many functions in the skin, including its role in
regulating the transport of different chemical compounds
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into the skin. Thus, skin is a largest integumentary organ
that can be approached to deliver different drugs or active
compounds by topical or transdermal route. Active and
passive skin penetrations have been achieved over the last
few decades, improving the efficiency of either transdermal
delivery (the drugs are delivered into subcutaneous tissue,
therefore, taken up systemically into the body) or topical
delivery (this method allows the drug delivery into skin
strata). Topical therapies are an alternative treatment for
several types of skin disorder as skin cancer, contact der-
matitis, and psoriasis, which the drugs are delivered
directly into skin strata (Zhang et al. 2014). Transdermal
and topical delivery systems ensure additional advantages
over other delivery routes, viz.: provide enhanced bio-
compatibility by evading the hepatic first-pass metabolism,
support patient compliance by decreasing the drug dosage
and at the same time maintaining the therapeutic effect of
the drug, and enhance the bioavailability of the therapeutic
agent at the targeted tissue or cells. While adopting trans-
dermal drug delivery administration route, drug penetration
is the point of prime concern. In this context, usage of
nanoparticles is reported to enhance the drug penetration
efficiency across the skin barrier and mucous membrane
(Zheng et al. 2012).
Transdermal drug delivery system is an important route
to deliver drugs into the body; the delivery through this
approach is focusing in many alternatives to overcome
some crucial problems related to the protective barrier of
the skin. This approach may offer several advantages; since
the skin is the biggest organ in the human body, it repre-
sents a relatively and readily accessible surface area for
drugs absorption. The delivery of medication through
transdermal route is less invasive when compared to other
approaches, such as intravenous and oral route; this last
approach can lead to drug degradation under extreme
acidity of the stomach, and might interact with food,
causing erratic delivery. The transdermal route also offers a
non-invasive procedure that allows continuous intervention
and monitoring. In addition to that, this approach allows
ceasing the drugs or compounds absorption, preventing
undesired effects and overdose (Contreras 2007). On the
other hand, this method has some disadvantages, as not all
compounds available worldwide are suitable as nanocarri-
ers across the skin. The penetration rate can vary from one
skin type to the other, depending upon the application site,
race, age, and the type of skin disease under treatment, etc.
An excellent transdermal delivery system should provide
adequate release drug formulation, and, at the same time,
allows considerable amount to overcome the skin barrier. It
is necessary to develop biocompatible drugs to avoid skin
irritation, which worsens patient’s health condition.
Transdermal drug delivery must ensure that the drug will
not be inactivated on the skin’s surface or even during the
penetration process (Langer 2004). While developing
nanofibrous wound dressings for tissue engineering, some
researchers have reported enhanced proliferation of human
dermal fibroblast (HDF) on electrospun mats surface (Jin
et al. 2013).
In the last years, controlled-release dosage form as bio-
compatible and injectable biodegradable polymeric parti-
cles, including poly(lactic-co-glycolic acid) (PLGA), has
been employed to avoid the invasive approach of surgical
intervention and implants. The crystallinity of the PLGA
polymer is directly related to its swelling behavior,
mechanical strength, subsequently its biodegradation rate,
its hydrolysis capability which further depends on the
molecular weight, and the molar ratio of the lactic and gly-
colic in the polymer chain (Wu 1995; Gilding and Reed
1979; Lewis 1990). PLGA is approved as amaterial to design
DDS for parental approach by the European Medicine
Agency and the US Food and Drugs Administration. PLGA
is used worldwide for the preparation of intravenous (DDS)
and biomimetic materials, and it has extensive applications
prospects in tissue engineering, medical imaging, drugs
delivery, and disease diagnosis (Kocbek et al. 2007). It
possesses attractive properties as drug delivery carrier,
including biocompatibility and biodegradability, it protects
drugs fromdegradation, the particles can target some specific
cells, its system adapts to various types of drugs, hydrophilic
or hydrophobic macromolecules, or small molecules, it has
sustained release possibility, and possesses flexible surface
properties that can be tuned as per the concerned application.
Zhang et al. (2013) have reported the surface modification of
PLGA to enhance a better efficacy of the drug, increasing the
drug availability at specific areas with delivery in a sustained
manner. The surface modification can be achieved by
depositing few atomic layer thick biocompatible polymers
coating, e.g., polyethylene glycol (PEG), to tune the
hydrophilicity, stability, and the aggregation ability of the
PLGA-based nanocarriers. In addition, the drug delivery
vehicle can be decorated with different functional groups
which can be used to bindwith the drugmolecules or specific
ligand molecules to enhance the drug specificity.
In the present review, we have compiled the literature
reporting different PLGA-based transdermal drug delivery
systems and revealed their implications over the other
administration routes.
PLGA-based transdermal drug delivery systems
PLGA-based microneedles for transdermal drug
delivery
Delivering pharmacologically active molecules into deeper
layers of the skin can be achieved using microneedles
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(MNs), which would minimize the pain in patients, bio-
safety, and might be useful as self-applicable systems
(Demir et al. 2013). This approach is considered as a
miniaturized novel device. It possesses several needles less
than 22 mm height on assembling. The use of MNs pro-
vides small hydrophilic drugs delivery, as well as the
transportation of lipophilic and macromolecular therapeu-
tics agents. MNs can deliver drugs through the stratum
corneum (SC). It is of great importance to select micro-
needle application approach and type. Polymeric MNs have
specific application in transdermal drug delivery, due to
their capacity to avoid cross-contamination. In addition to
that, the selected materials can be used to optimize the
desired application and behavior as swelling, degradation,
and dissolution. Figure 1 shows the microneedles designed
using different polymers, such as sodium alginate (SA),
hydroxypropyl cellulose (HPC) (M and H grades), cross-
linked polyvinyl alcohol (PVA), and gelatin hydrogels,
chitosan, and poly(lactic-co-glycolic acid) (PLGA) (Demir
et al. 2013).
Ke et al. (2012) have reported a novel approach to deliver
two model drugs transdermally. They used poly vinyl
pyrrolidone (PVP) due to its strongbehavior for skin insertion.
PVP is approved by the US Food and Drug Administration
(FDA) for many drug delivery applications. In another study,
PVP has been reported to design microneedles that can be
quickly dissolved in the skin, leaving behind no biohazardous
sharp points and delivering the encapsulated drugs (Donnelly
et al. 2011). In another study, Ke et al. have simultaneously
encapsulated both Alexa 488 and Cyanine5 (Cy5) loaded
PLGA microspheres together into PVP MNs. Authors have
used double emulsion method to develop pH-responsive
PLGA hollow microspheres (HMs); the aqueous core based
on sodium bicarbonate (NaHCO3) and Cy5, and the shell
contained Dil (1,10-dioctadecyl-3,3,30,30-tetramethyl indo-
carbocyanine perchlorate). Subsequently, using PDMSmold,
PVP MN arrays were fabricated containing PLGA HMs and
Alexa 488.Healthy skin is acidic, with pH ranging from4.2 to
5.6. However, the epidermis pH value is approximately 5.5;
the skin cancer has been reported and observed to develop at
the epidermis layer. This smart PLGA-based microneedle
design is reported to release both encapsulated drugs in two
phases and helps achieving different timescales of controlled
release.As soon as they inserted theMNs into the skin, the first
step that was observed was the rapid release of Dil-labeled
HMs Alexa 488, related to the quick dissolution of PVP
polymers. The second phase of the drug release is due to the
exposure of Dil-labeled HMsAlexa 488 to the skin condition,
which has acidic behavior in natural conditions. The release
process happens when the HMs-w-NaHCO3 reacts with the
acid (H?), generating CO2 bubbles, intruding through the
HMs, and releasing the encapsulated Cy5 (Fig. 2).
Fig. 1 Digital photographs of sections from 10,610 dissolvable MNs
fabricated from PDMS micromolds. a sodium alginate microneedles,
b hydroxypropyl cellulose, c hydroxypropyl cellulose, d cross-linked
swellable polyvinyl alcohol-gelatin, e chitosan, and f PLGA with
permission from Demir et al. (2013)
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In another study (Park et al. 2006), authors have reported
the development of polymericmicroneedles for developing
controlled DDS, involving microelectromechanical system
(MEMS) techniques which were used to make molds, fab-
ricating microneedles based on biodegradable and biocom-
patible polymers (Fig. 3). The microneedles developed have
the height of 600 lm, tip radius of 5 lm, and base radius of
50 lm. The entire array area is 9 9 9 mm, where the nee-
dles were positioned in a 20 9 6 arrays with center-to-
center spacing between needles of 400 and 1400 lm.
PLGA nanoparticles for transdermal drug
delivery
A common pharmaceutical strategy is the encapsulation of
active substances to modify the release properties and the
transport of a drug. The nanoparticle systems are a great
potential for DDS. As a consequence of the fact that, some
sensitive drugs could be hidden from degradation in the
particles (Stracke et al. 2006). The nanoparticles (NPs) for
pharmaceutical purposes are defined as solid colloidal
particles ranging in size from 10 to 400 nm. Different
polymers can be used to develop nanoparticles (Dinarvand
et al. 2011). Synthetic polymeric nanoparticles are the
mainly used in designing DDS, since natural polymers
broadly vary in their degree of purity. On the contrary,
using synthetic polymers, a good porosity can be achieved
and nanoparticles can be modelled (Panyam and Lab-
hasetwar 2003). Commonly used synthetic polymers for
drug delivery application, among many, include PLGA.
Figure 4 presents the chemical backbone of PLGA with the
TEM image showing the PLGA nanoparticles (Acharya
and Sahoo 2011).
Some drug penetration evaluation methods into the skin
are mostly destructive; a representative sample of defined
Fig. 2 Schematic illustration of the design of PVP MN arrays
containing pH-responsive PLGA HMs and their mechanism for co-
delivery of two different model drugs Alexa 488 and Cy5 in sequence
transdermally. After insertion into skin, the first step of rapid release
of Alexa 488 and Dil-labeled HMs was accomplished due to quick
dissolution of PVP polymers. The second-step release of Cy5 from
HMs was stimulated by the acidic skin environment. PVP MNs:
polyvinylpyrrolidone microneedles; PLGA HMs: poly(DL-lactic-co-
glycolic acid) hollow microspheres With permission from Elsevier
(Ke et al. 2012)
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skin layer is isolated and, therefore, extracted for chemical
analysis, such as: cryo-sectioning and tape stripping
method (Brain et al. 2002). As a result of such tests, it is
possible to obtain some data, regarding the deep profile of
drug location into the skin versus release time (Luengo
et al. 2006). For the characterization of the depth, it is
necessary to perform investigation using multiple samples
and employing more versatile techniques to optimize and
evaluate novel dermal drug delivery strategies for drugs in
nanoscale size. Following the application of nanoparticles
as topical vehicles, the penetration may be achieved
through different routes. It can be assumed that the
nanoparticles may enter once the nanocarrier is decom-
posed closer to the skin surface or the nanoparticulate
systems are taken up without being destroyed (Kohli and
Alpar 2004). Thereafter, the penetration absorption rate of
the active substance may depend upon local environment,
such as absorption or acidification of nanoparticles/drug
complexes (Stracke et al. 2006).
The particle size of PLGA is the key factor in deciding
its biodistribution and therapeutic efficacy. Nanoparticles
of PLGA with range size smaller than 100 nm showed
higher cells uptake in the combination of polymer
hydrophilicity behavior and surface charge (Bilati et al.
2005). In our skin, hair follicles occupy approximately
0.1% of the total surface area. The hair follicles play a
significant role in the nanoparticles penetration, as they
increase the absorption area below the skin surface. Some
researchers point out that particle penetration is related to
the ‘‘activity’’ of the follicles, likewise the sebum pro-
duction and hair growth (Contreras 2007). In Fig. 5, it is
possible to observe the follicular route for nanoparticles
penetration, appearing as a promising approach for drug
delivery.
Nanoparticles can be delivered through transdermal
pathways, confirmed by the work of many researchers, and
the recent development of engineered nanomaterials and
the development of nanotechnology. The use of these
Fig. 3 Microscopy images of
microneedles. A section of an
array of a microneedles,
b tapered-cone microneedles,
c bevel-tip, d tapered-cone
microneedles made of PLGA,
e PLGA microneedle showing
microparticles, and f a complete
PLGA microneedle arrays With
permission from Springer (Park
et al. 2006)
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nanomaterials is useful, since they can penetrate deeper
into the protective layer of skin, delivering drugs or active
agents and nutrients, such as non-synthetic peptide that
instruct cells to regenerate, as some of these nanoparticles
have antioxidant properties (Xiao et al. 2005). The gamut
of nanoparticles used in products delivered through trans-
dermal pathways is assumed to have health effects which
are not yet known, though some of these nanoparticles have
been considered safe in the past. Nonetheless, there are
now some nano-toxicological concerns; as an example, we
can cite silver, which has widely been used due to its
antimicrobial activity. Nowadays, it is found that silver at
nanoparticle scale might provoke adverse toxicity effects to
animals and humans (Soto et al. 2005). Inhalation of the
silver nanoparticle can provoke acute problems to the cir-
culatory systems, heart, and kidneys (Takenaka et al.
2001). In this case, the use of nanoparticle-sized materials
instead of helping the patients to fight their disease can lead
to several unpleasant complications that may cause severe
infection or even death. The small nanoparticle size can
influence some important cellular regulatory process, such
as proliferation, metabolism, and death. The dysfunction of
these essential cellular processes can be associated with
many diseases as well as a neurodegenerative disease or
cancer when the disease causes part of premature cell death
or uncontrolled cell proliferation, respectively (Antonini
et al. 2006).
Nanoparticles can enter cells like nano-organisms, as
viruses for example. By doing so, once these nanoparticles
are absorbed, they can interact with subcellular structures
and mechanisms. The nanoparticle size, chemistry, and
shape are directly related to the cellular uptake, ability to
catalyze oxidative products and subcellular localization
(Xia et al. 2006). Molecules with a diameter of 0.7 nm can
penetrate cells via different mechanisms, probably through
pores in the cell membrane or ion channels (Porter et al.
2006). This type of free movement and uptake of the cell
might have harmful consequences, once it is easily acces-
sible to cytoplasm organelles and proteins. Depending on
the localization of the nanoparticles inside the cells, they
can damage the DNA or organelles, or ultimately cause cell
death. The nanoparticles can be found in different regions
inside the cells, upon non-phagocytic uptake, such as the
outer membrane, mitochondria (Li et al. 2003), cytoplasm,
Fig. 4 a Chemical structure of PLGA where, m represents number of
units of lactic acid and n represents number of units of glycolic acid;
b (TEM) of PLGA nanoparticles With permission from Elsevier
(Acharya and Sahoo 2011)
Fig. 5 Images showing skin surface and saturated absorption of isothiocyanate followed by 30 min (a), 1 h (b), and 2 h (c). Possible
nanoparticle route through follicular pathway (Alvarez-Romn et al. 2004) With permission from Elsevier
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and lipid vesicles (Garcia-Garcia et al. 2005), within the
nucleus (Xia et al. 2006) or along the nuclear membrane.
PLGA nanofibers for transdermal drug delivery
Medication of drugs plays important role in the medical
field. However, most drugs are absorbed only when their
concentration in the blood is above their minimal effective
level. Each drug has its own half-life and it is not possible to
maintain the concentration for a long time. By increasing the
drug dosage, subsequently, the patients are under a higher
toxicity risk, which is not convenient for the patient (Meng
et al. 2011). Electrospinning technique has received con-
siderable interest for nanofiber engineering to produce new
systems for drugs delivery through transdermal pathways.
Using this method, it is possible to fabricate porous
nanofibrous materials with some specific characteristics like
three-dimensional morphologies, high porosity, large sur-
face area, and volume ratio. The use of this technique allows
manufacturing nanofibers from natural or synthetic poly-
mers. Electrospun nanofibers can be used as template for the
production of drug loaded polymers. These biodegradable
polymers as drug carriers can act as an adjuvant, protecting
the drug from corrosion of enzymes and gastric acid, pre-
serving the drug activity (Meng et al. 2011).
Ajalloueian and co-workers (2014) stated that: lactide
and glycolide are the most used synthetic polymers for
electrospinning technique. These synthetic polymers have
excellent mechanical properties and are biodegradable. Its
hydrophobic structure results in a reduced cell-scaffold
attachment interaction due to the lower surface energy. The
product degradation is related to its acidity and negative
surface charge.
Several factors might interfere with the electrospinning
process, such as emulsion concentration, feed rate, applied
voltage, and tip to collector distance. By reducing the
polymer concentration in the emulsion, the average diam-
eter of the electrospun nanofiber is decreased, which is
related to the lower emulsion viscosity (Meng et al. 2010).
Higher concentration of PLGA produces an emulsion
which is very viscous for electrospinning.
It has been reported (Ajalloueian et al. 2014) that, when
using high voltage of 16 kV, it is possible to achieve more
uniform nanofiber; by decreasing the voltage to 12 kV, the
nanofibers are less consistent; and at the voltage of 8 kV, it
is possible to observe the formation of some beads along
the electrospun nanofibers. The higher the voltage applied
to the process of electrospinning, the better properties are
obtained as more uniform, beads-free, and finer nanofiber
formation. The distance between the Taylor cone and the
collector in the range of 8–15 cm does not show any sig-
nificant effect on the diameter of electrospun.
In another study (Qi et al. 2016), there was a report on
the development of doxorubicin (Dox), loaded with PLGA
and multi-walled carbon nanotubes (MWCNTs) to encap-
sulate a model anticancer drug for the development of
electrospun mats. The biocompatibility, cell proliferation,
and greater adhesion of dermal fibroblasts on the surface of
the mats can be observed in Fig. 6. SEM micrographs of
this electrospun mats are shown in Fig. 7. The authors have
reported that after loading doxorubicin into PLGA solution,
the Dox/PLGA bleb fibers were much smaller than pure
PLGA fibers. It is known that the electrospinning solution
property can significantly be affected by the addition of
cationic or anionic species. The introduction of doxoru-
bicin, cationic drug, may cause an increase in the surface
density of the spinning jet, therefore, resulting in a smaller
fiber diameter. The authors have reported that the use of
these biocompatible electrospun mats might have a
potential application in tissue engineering and local post-
operative chemotherapy.
The extracellular matrix (CCM) is the natural scaffold
for most of tissues, whose morphology and structure con-
tribute greatly to the function and properties of each organ.
It can be an adjuvant for the elasticity of the skin (Bottaro
et al. 2002). To mimic the natural function of the organs,
many researchers are exploring the possibility of using and
developing new copolymers biochemical/biopolymers,
incorporating growth factor, biological agents, and some
other key cell regulatory molecules (Luu et al. 2003).
Nanostructure evaluation techniques
Scanning electron microscopy
Scanning electron microscopy (SEM) technique can be
used to visualize and analyze the surface morphology of
the nanostructures, including nanoparticles, nanofibers,
microspheres, etc. It employs finely focused electron beam
to image the surface of the specimen. This technique was
explained by Jacob (1952) as per which the instrument
consists of an electron gun, which produces an electron
beam, focused on the specimen surface. The computer
memory is measured and stored the intensities of various
signals created by the interaction between the sample
scanned area and the size displayed images.
Energy-dispersive X-ray spectroscopy
This technique can be used to do the chemical characteri-
zation or/and elemental analysis of the sample, and it
determines the quantitative elemental composition of the
sample. This characterization is based on the fact that each
chemical element has its unique atomic structure which
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allows to set-up individual peaks on its X-ray emission
spectrum. A high-energy beam of X-rays or beam of
charged particles like protons or electrons is focused into
the sample. Before the high-energy beam incident on the
sample, the sample is found in the unexcited state where
the atoms are in discrete energy level. The exposed beam
provokes an excitement of the electrons found in the inner
shell, ejecting it from the shell, consequently, creating
electron hole. This phase is followed by the removal of an
electron from an outer higher energy shell filling the hole,
as a result of this ejection of the electron from the shell, an
X-ray is released, and it is the difference in energy between
the high-energy shell and the lower energy shell. The
energy of X-rays emitted from the sample is measured by
the energy-dispersive spectrometer (Hafner 2006).
X-ray diffraction
X-ray diffraction (XRD) relies on the dual wave/particle
nature of X-rays to obtain information about the structure
of crystalline materials. This technique is used for evalu-
ating crystallinity of the polymers. In 2008, Petkov (2008)
stated that the atomic-scale structure of materials is
determined by X-ray diffraction technique. By doing so, it
is possible to analyze the distance between atoms in con-
densed matter, which is comparable to the wavelengths in
X-ray range. When a material, such as crystal, is irradiated
with X-rays, it exhibits Bragg diffraction peaks, which is
the diffraction pattern showing numerous sharp spots. The
arrangement of the atoms in the crystalline materials and
its 3D atomic position can be determined by analyzing and
measuring the intensities and the position of Bragg
diffraction peaks.
Transmission electron microscopy
While using transmission electron microscopy, the impor-
tant components are vacuum system, an electron optical
column, the necessary electronics (the high voltage gen-
erator for the electron source and the lens to focus and
deflect beams). This technique is suitable for observing
animal and plants cells at high magnifications, to obtain
cell information. The specimens must be thin, for achieving
the transition of the electron beams, typically 0.5 lm or
less. Using high accelerating voltages, higher energy of
electrons is obtained, which can penetrate the thicker
samples. Vacuum is used to perform this technique, which
allows the entire electron path from the gun into the
camera. Otherwise, the electron beams would collide with
air molecules and absorbed or scattered (Jacob 1952).
Conclusions
In conclusion, with the growing advancements in the field
of nanotechnology, new paradigms have developed in
novel approaches and strategies to design efficient
nanomedicines targeting different diseases. Efficient drug
delivery system (DDS) pertains to the chemically
stable biodegradable delivery vehicles that can release drug
at the targeted tissue or area, minimize the therapeutic side-
effects, and also conserve sustained release for a longer
duration. PLGA is found to be a promising synthetic
Fig. 6 Human dermal
fibroblast growth a tissue
culture plate (TCP),
b PLGAmats, MWCNTs/PLGA
nanofibers with 3 wt% (c) and
5% (d) of multi-walled carbon
nanotubes relative to PLGA
With permission from Springer
(Qi et al. 2016)
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Fig. 7 SEM images and
corresponding fiber diameter
distribution histograms of the
electrospun mats. a Doxorubicin
blended with PLGA 1 wt % of
Doxorubicin relative to PLGA,
b, c, d blended mats of
doxorubicin/multi-walled
carbon nanotubes and PLGA
containing, respectively, 1, 2,
and 3 wt% of doxorubicin
relative to PLGA With
permission from Springer (Qi
et al. 2016)
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polymer for different biomedical applications, including
their implications in designing competent drug delivery
systems. Using PLGA, it is possible to encapsulate variety
of drugs like hydrophilic or hydrophobic with size ranging
from small molecules to macromolecules to deliver them at
various targeted locations using different administration
routes, including intravenous drug delivery, pulmonary
drug delivery, transdermal drug delivery, etc. Further to
enhance the loading efficiency and specificity of the drug
delivery carrier, PLGA surface properties can be tuned
using different coating protocols and functionalization
strategies. PLGA is also reported as efficiently designed in
DDS for transdermal drug delivery in the form of micro-
needle arrays, nanoparticles, and nanofiber mats. SEM,
TEM, EDX, and XRD are some of the morphological and
structural analysis techniques to study PLGA micro- and
nanostructure-based DDS.
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